We have previously reported that parenteral amino acid intakes reduce the risk of both hyperglycaemia and insulin treatment, and this may in part account for the similar mean blood glucose profiles and frequency of insulin treatment seen for the SCAMP and control infants [23,42,43]. This evidence concerns the gene INS and Hyperglycemia.